ENTRY       D02714                      Drug
NAME        Everolimus (JAN/USAN/INN);
            Afinitor (TN);
            Votubia (TN);
            Zortress (TN)
PRODUCT     AFINITOR (Novartis Pharmaceuticals Corporation)
            ZORTRESS (Novartis Pharmaceuticals Corporation)
  GENERIC   EVEROLIMUS (Ascend Laboratories)
            EVEROLIMUS (Biocon Pharma)
            EVEROLIMUS (Breckenridge Pharmaceutical)
            EVEROLIMUS (Breckenridge Pharmaceutical)
            EVEROLIMUS (Hikma Pharmaceuticals USA)
            EVEROLIMUS (Hikma Pharmaceuticals USA)
            EVEROLIMUS (Mylan Pharmaceuticals)
            EVEROLIMUS (Mylan Pharmaceuticals)
            EVEROLIMUS (Natco Pharma Limited)
            EVEROLIMUS (Natco Pharma Limited)
            EVEROLIMUS (Par Pharmaceutical)
            EVEROLIMUS (Par Pharmaceutical)
            EVEROLIMUS (Teva Pharmaceuticals USA)
FORMULA     C53H83NO14
EXACT_MASS  957.5814
MOL_WEIGHT  958.2244
CLASS       Antineoplastic
             DG01597  mTOR inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
REMARK      Therapeutic category: 3999 4291
            ATC code: L01EG02 L04AA18
            Product: D02714<JP/US>
EFFICACY    Antineoplastic, Immunosuppressant, mTOR inhibitor
  DISEASE   Breast cancer (HR positive, HER2 negative) [DS:H00031]
            Pancreatic neuroendocrine tumor [DS:H00045]
            Renal cell carcinoma [DS:H00021]
            Tuberous sclerosis complex-associated renal angiomyolipoma [DS:H01691]
            Tuberous sclerosis complex-associated subependymal giant cell astrocytoma [DS:H01692]
            Organ rejection in kidney transplantation [DS:H00083]
            Organ rejection in liver transplantation [DS:H00083]
COMMENT     Rapamycin derivative
TARGET      MTOR [HSA:2475] [KO:K07203]
  PATHWAY   hsa04012(2475)  ErbB signaling pathway
            hsa04150(2475)  mTOR signaling pathway
            hsa05200(2475)  Pathways in cancer
            hsa05224(2475)  Breast cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
            Transporter: ABCB1 [HSA:5243]
INTERACTION  
STR_MAP     map07042  Antineoplastics - agents from natural products
            map07045  Antineoplastics - protein kinase inhibitors
            map07046  Immunosuppressive agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
                 L01EG02 Everolimus
                  D02714  Everolimus (JAN/USAN/INN) &lt;JP/US&gt;
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA18 Everolimus
                  D02714  Everolimus (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Everolimus
                D02714  Everolimus (JAN/USAN/INN)
             Immunological Agents
              Immunosuppressants
               mTOR Inhibitors
                Everolimus
                 D02714  Everolimus (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D02714  Everolimus (JAN/USAN/INN)
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D02714  Everolimus (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01597  mTOR inhibitor
               D02714  Everolimus
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D02714  Everolimus
             Transporter substrate
              DG01665  ABCB1 substrate
               D02714  Everolimus
            Drug classes [BR:br08332]
             Antineoplastic
              DG01597  mTOR inhibitor
               D02714  Everolimus
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               Other
                MTOR
                 D02714  Everolimus (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02714
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02714
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02714
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02714
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02714
             Drug transporters
              D02714
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D02714
DBLINKS     CAS: 159351-69-6
            PubChem: 17396881
            ChEBI: 68478
            LigandBox: D02714
ATOM        68
            1   N1y N    28.0564  -21.8335
            2   C1y C    29.2458  -21.1339
            3   C5a C    28.0564  -23.2326
            4   C1x C    26.7971  -21.1339
            5   C7a C    30.4350  -21.8335
            6   C1x C    29.2458  -19.7348
            7   C5a C    26.7971  -23.9323
            8   O5a O    29.2458  -23.9323
            9   C1x C    26.7971  -19.7348
            10  O7a O    31.6243  -21.1339
            11  O6a O    30.4350  -22.9530
            12  C1x C    28.0564  -18.9652
            13  C1z C    26.7971  -25.3315
            14  O5a O    25.6079  -23.1628
            15  C1c C    32.8836  -21.8335
            16  O2x O    27.9864  -26.0311
            17  C1y C    25.5378  -26.0311
            18  O1a O    26.7971  -26.7307
            19  C1c C    34.0729  -21.1339
            20  C1b C    32.8836  -23.2326
            21  C1y C    27.9864  -27.4303
            22  C1x C    25.5378  -27.3603
            23  C1a C    24.3486  -25.2615
            24  C1b C    35.3321  -21.8335
            25  C1a C    34.0729  -19.7348
            26  C5a C    34.0729  -23.9323
            27  C1b C    29.1758  -28.1299
            28  C1x C    26.7971  -28.1299
            29  C1y C    36.5215  -21.1339
            30  C1c C    34.0729  -25.3315
            31  O5a O    35.3321  -23.1628
            32  C1c C    29.1758  -29.5291
            33  C1x C    37.7108  -21.8335
            34  C1x C    36.5215  -19.7348
            35  C2b C    35.3321  -26.0311
            36  C1a C    32.8836  -26.0311
            37  C2c C    30.3650  -30.2287
            38  O2a O    27.9864  -30.2287
            39  C1y C    38.9001  -21.1339
            40  C1x C    37.7108  -19.0352
            41  C2c C    35.3321  -27.3603
            42  C2b C    30.3650  -31.6279
            43  C1a C    31.6243  -29.5291
            44  C1a C    27.9864  -31.6279
            45  C1y C    38.9001  -19.7348
            46  O2a O    40.1594  -21.8335
            47  C1c C    36.5215  -28.0599
            48  C1a C    34.0729  -28.0599
            49  C2b C    31.5544  -32.3275
            50  O2a O    40.1594  -18.9652
            51  C1c C    36.5215  -29.4591
            52  O1a O    37.7108  -27.3603
            53  C2b C    31.5544  -33.7266
            54  C5a C    37.7108  -30.1587
            55  O2a O    35.2623  -30.1587
            56  C2b C    32.8137  -34.4262
            57  C1c C    37.7108  -31.5579
            58  O5a O    38.9001  -29.4591
            59  C1a C    35.2623  -31.5579
            60  C2b C    34.0029  -33.7266
            61  C1b C    36.5215  -32.2575
            62  C1a C    38.9001  -32.2575
            63  C1c C    35.4021  -33.7266
            64  C1a C    35.7519  -35.0559
            65  C1b C    41.4068  -19.6446
            66  C1b C    42.6136  -18.9066
            67  O1a O    43.8531  -19.5813
            68  C1a C    40.1594  -23.2335
BOND        71
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1 #Up
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 1
            12    7  13 1
            13    7  14 2
            14   10  15 1
            15   13  16 1 #Down
            16   13  17 1
            17   13  18 1 #Up
            18   15  19 1
            19   15  20 1
            20   21  16 1 #Down
            21   17  22 1
            22   17  23 1 #Up
            23   19  24 1
            24   19  25 1 #Down
            25   20  26 1
            26   21  27 1
            27   21  28 1
            28   24  29 1
            29   26  30 1
            30   26  31 2
            31   27  32 1
            32   29  33 1
            33   29  34 1
            34   30  35 1
            35   30  36 1 #Up
            36   32  37 1
            37   32  38 1 #Up
            38   33  39 1
            39   34  40 1
            40   35  41 2
            41   37  42 2
            42   37  43 1
            43   38  44 1
            44   39  45 1
            45   39  46 1 #Down
            46   41  47 1
            47   41  48 1
            48   42  49 1
            49   45  50 1 #Up
            50   47  51 1
            51   47  52 1 #Up
            52   49  53 2
            53   51  54 1
            54   51  55 1 #Down
            55   53  56 1
            56   54  57 1
            57   54  58 2
            58   55  59 1
            59   56  60 2
            60   57  61 1
            61   57  62 1 #Down
            62   60  63 1
            63   63  64 1 #Down
            64    9  12 1
            65   22  28 1
            66   40  45 1
            67   61  63 1
            68   50  65 1
            69   65  66 1
            70   66  67 1
            71   46  68 1
///
